Title of article
Breaking the LSD1/KDM1A Addiction: Therapeutic Targeting of the Epigenetic Modifier in AML
Author/Authors
Lokken، نويسنده , , Alyson A. and Zeleznik-Le، نويسنده , , Nancy J.، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2012
Pages
3
From page
451
To page
453
Abstract
KDM1A/LSD1, a histone H3K4/K9 demethylase and epigenetic regulator with roles in both gene activation and repression, has increased expression in multiple cancer types. Harris et al., in this issue of Cancer Cell, and Schenk et al. show that KDM1A may be a viable therapeutic target in treating AML.
Journal title
Cancer Cell
Serial Year
2012
Journal title
Cancer Cell
Record number
1337849
Link To Document